Atai Life Sciences Cash on Hand 2020-2023 | ATAI
Atai Life Sciences cash on hand from 2020 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Atai Life Sciences Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $179 |
| 2022 | $273 |
| 2021 | $362 |
| 2020 | $97 |
| 2019 | $30 |
| Atai Life Sciences Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2023-12-31 | $179 |
| 2023-09-30 | $209 |
| 2023-06-30 | $227 |
| 2023-03-31 | $250 |
| 2022-12-31 | $273 |
| 2022-09-30 | $304 |
| 2022-06-30 | $312 |
| 2022-03-31 | $124 |
| 2021-12-31 | $362 |
| 2021-09-30 | $430 |
| 2021-06-30 | $454 |
| 2021-03-31 | $104 |
| 2020-12-31 | $97 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | $30 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.323B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.392B | 9.92 |
| Quest Diagnostics (DGX) | United States | $14.915B | 15.41 |
| DaVita (DVA) | United States | $11.709B | 15.93 |
| Chemed (CHE) | United States | $8.472B | 26.30 |
| Encompass Health (EHC) | United States | $8.259B | 21.25 |
| Elanco Animal Health (ELAN) | United States | $6.552B | 14.90 |
| Option Care Health (OPCH) | United States | $5.147B | 19.48 |
| RadNet (RDNT) | United States | $3.314B | 96.80 |
| Amedisys (AMED) | United States | $2.999B | 21.25 |
| LifeStance Health (LFST) | United States | $2.370B | 0.00 |
| Astrana Health (ASTH) | United States | $2.057B | 25.68 |
| Addus HomeCare (ADUS) | United States | $1.548B | 23.52 |
| U.S Physical Therapy (USPH) | United States | $1.516B | 39.30 |
| Pennant (PNTG) | United States | $0.624B | 36.46 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.423B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.029B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.018B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.014B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.005B | 0.00 |